Cbl-b over-expression inhibited saturated fatty acid-induced toll-like receptor 4 (TLR4) signaling, as it mediates TLR4 ubiquitination and degradation in macrophages, leading to modulated TLR4 protein levels on the cell surface, thereby improving insulin resistance in the liver (113, 114). Here, TLR4 is linked to Insulin resistance.